Aquinnah Pharmaceuticals, a Cambridge, MA-based developer of therapies to slow the progression of ALS and other neurodegenerative diseases, received $5M in private equity funding. Takeda Pharmaceutical Company made the investment. Aquinnah Pharmaceutical’s approach is unique by integrating human genetic, human…